Sg3 Management, LLC Sage Therapeutics, Inc. Put Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 15, 2022	BUY	$27.52 - $37.99 $412,800 - $569,850	15,000 Added 40.0%	52,500 $1.7 Million
Q1 2022 May 16, 2022	SELL	$30.71 - $45.71 $2.13 Million - $3.18 Million	-69,500 Reduced 64.95%	37,500 $1.24 Million
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $318,054 - $453,223	-7,900 Reduced 6.88%	107,000 $4.74 Million
Q2 2021 Aug 16, 2021	SELL	$54.88 - $79.29 $2.73 Million - $3.94 Million	-49,700 Reduced 30.19%	114,900 $6.53 Million
Q1 2021 May 17, 2021	BUY	$70.65 - $96.76 $11.6 Million - $15.9 Million	164,600 New	164,600 $12.3 Million

222

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $641M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.